Madam Therapeutics
We are an innovative biotech company developing a proprietary new class of antibiotics that are active against drug-resistant bacteria.
- Stage Product In Development
- Industry Biotechnology
- Location 1078 Amsterdam, NH, The Netherlands
- Currency EUR
- Founded March 2011
- Employees 2
- Website madam-therapeutics.com
Company Summary
Our first product will improve the quality of life for 80-100 million atopic dermatitis patients worldwide. We develop it up to and including phase II clinical studies before licensing to a partner. The program management and business development are internal, all the other activities are outsourced. We are in pre-clinical development (financed), and are looking for financing for the clinical development which is anticipated to commence H2-2014.
Team
-
Remko van LeeuwenChief Executive Officer
Remko has extensive medical and regulatory experience in drug development. He is an experienced clinical trialist/epidemiologist with focus on infectious diseases with >20 years of experience in working in global clinical trials. He is coordinator of several international drug/vaccine development consortia. He has also build up commercial experience at a CRO, being responsible for clinical study BD and financing.
-
Michel de BaarChief Business Officer
Michel has over 15 years experience in program management and business development and licensing in the international pharma/biotech industry. Having worked with any type of organization, from small biotech to large pharma, he has build up a vast network. Furthermore, Michel has shown creativity to successfully structure licensing, co-development and partnering deals with any type of company taking all parties' needs and wishes into account.
Advisors
-
Axon Lawyers & NautaDutilh NetherlandsLawyerUnconfirmedde Nieuwenhuizen GroepAccountantUnconfirmed
Previous Investors
-
noneUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.